Exelixis Inc (EXEL)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Michael M. Morrissey |
| Employees: | 1,220 |
| Web site: | exelixis.com |
|
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
6508377000
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Exelixis, Inc. focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Its products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma.
Please log in first to see chart